Y Wan1,2, Y-Q Zhu3, N-W Chen4, Z-G Wang5, Y-S Cheng6, J Shi7. 1. Department of Hematology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, No. 600, Yi Shan Road, Shanghai, 200233, China. 2. Department of Oncology, Kunshan Hospital of Traditional Chinese Medicine, Kunshan, China. 3. Department of Radiology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, No. 600, Yi Shan Road, Shanghai, 200233, China. zhuyueqi@hotmail.com. 4. Department of Gastroenterology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China. 5. Department of Surgery, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China. 6. Department of Radiology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, No. 600, Yi Shan Road, Shanghai, 200233, China. 7. Department of Hematology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, No. 600, Yi Shan Road, Shanghai, 200233, China. shijunsl@126.com.
Abstract
BACKGROUND: The aim of the present study was to compare the feasibility, safety and efficacy of the through-the-scope (TTS) stent technique to that of the standard metallic stent technique for the management of malignant colorectal obstruction. METHODS: Fifty-two patients scheduled to receive stent insertion for the management of acute obstructive colorectal cancer were enrolled in our study and divided into a TTS stent group (n = 24) and a standard stent group (n = 28). The stent insertion procedure was performed under endoscopic and fluoroscopic guidance in all patients. The success rate, complications, fluoroscopic time, and clinical remission rate were recorded and compared. RESULTS: The technique success rate was 100 % (24/24) in the TTS stent group and 78.6 % (22/28) in the standard stent group (p = 0.03). In five patients in the standard stent group, the stent failed to pass through occlusive lesions because of the stiffness of the stent system. Serious bleeding occurred in one patient in the standard stent group. The fluoroscopy time in the TTS stent group was significantly reduced (12.9 ± 6.6 min) compared with that of the standard stent group (24.8 ± 9.8 min; p < 0.01). Silent perforation occurred in 17.9 % (5/28) of the cases in the standard stent group compared with none in the TTS (p = 0.03). Clinical remission was achieved in 97.1 % (23/24) and 78.6 % (22/28) of patients in the TTS and standard stent groups, respectively (p = 0.11). CONCLUSIONS: The TTS stent is safer and more feasible for the management of malignant colorectal obstructions than the standard stent, and the TTS technique provides a higher success rate, a similar clinical remission rate, and a markedly reduced fluoroscopic time.
BACKGROUND: The aim of the present study was to compare the feasibility, safety and efficacy of the through-the-scope (TTS) stent technique to that of the standard metallic stent technique for the management of malignant colorectal obstruction. METHODS: Fifty-two patients scheduled to receive stent insertion for the management of acute obstructive colorectal cancer were enrolled in our study and divided into a TTS stent group (n = 24) and a standard stent group (n = 28). The stent insertion procedure was performed under endoscopic and fluoroscopic guidance in all patients. The success rate, complications, fluoroscopic time, and clinical remission rate were recorded and compared. RESULTS: The technique success rate was 100 % (24/24) in the TTS stent group and 78.6 % (22/28) in the standard stent group (p = 0.03). In five patients in the standard stent group, the stent failed to pass through occlusive lesions because of the stiffness of the stent system. Serious bleeding occurred in one patient in the standard stent group. The fluoroscopy time in the TTS stent group was significantly reduced (12.9 ± 6.6 min) compared with that of the standard stent group (24.8 ± 9.8 min; p < 0.01). Silent perforation occurred in 17.9 % (5/28) of the cases in the standard stent group compared with none in the TTS (p = 0.03). Clinical remission was achieved in 97.1 % (23/24) and 78.6 % (22/28) of patients in the TTS and standard stent groups, respectively (p = 0.11). CONCLUSIONS: The TTS stent is safer and more feasible for the management of malignant colorectal obstructions than the standard stent, and the TTS technique provides a higher success rate, a similar clinical remission rate, and a markedly reduced fluoroscopic time.
Authors: Hun Jin Kim; Jung Wook Huh; Wu Seong Kang; Chang Hyun Kim; Sang Woo Lim; Young Eun Joo; Hyeong Rok Kim; Young Jin Kim Journal: Surg Endosc Date: 2013-02-23 Impact factor: 4.584
Authors: Bo Kyung Kim; Sung Pil Hong; Hyun Mi Heo; Jin Young Kim; Hyuk Hur; Kang Young Lee; Jae Hee Cheon; Tae Il Kim; Won Ho Kim Journal: Gastrointest Endosc Date: 2011-12-09 Impact factor: 9.427
Authors: Jeanin E van Hooft; Emo E van Halsema; Geoffroy Vanbiervliet; Regina G H Beets-Tan; John M DeWitt; Fergal Donnellan; Jean-Marc Dumonceau; Robert G T Glynne-Jones; Cesare Hassan; Javier Jiménez-Perez; Søren Meisner; V Raman Muthusamy; Michael C Parker; Jean-Marc Regimbeau; Charles Sabbagh; Jayesh Sagar; Pieter J Tanis; Jo Vandervoort; George J Webster; Gianpiero Manes; Marc A Barthet; Alessandro Repici Journal: Endoscopy Date: 2014-10-17 Impact factor: 10.093
Authors: Joyce V Veld; Kim J Beek; Esther C J Consten; Frank Ter Borg; Henderik L van Westreenen; Wilhelmus A Bemelman; Jeanin E van Hooft; Pieter J Tanis Journal: Colorectal Dis Date: 2021-01-15 Impact factor: 3.788